Inverse Vaccines: A Promising Breakthrough in the Treatment of Autoimmune Diseases

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Inverse vaccines also known as tolerogenic vaccine are an innovative strategy in immunology, designed to promote immune tolerance instead of triggering an immune response. In contrast to conventional vaccines that activate the immune system to combat pathogens, the goal of tolerogenic vaccines is to suppress harmful immune reactions, making them particularly valuable for managing autoimmune disorders, allergies and issues related to organ transplantation. These vaccines function by specifically targeting self-reactive immune cells and enhancing regulatory mechanisms that maintain immune balance, all without broadly weakening the body’s natural defences. Progress in areas such as targeted antigen delivery, the use of tolerogenic dendritic cells and nanoparticle technologies has significantly improved the precision and potential of these vaccines. As a result, inverse vaccines are emerging as a promising therapeutic option for diseases like rheumatoid arthritis, multiple sclerosis and type 1 diabetes, offering a way to address the root causes of immune system dysfunction rather than just treating the symptoms.